Top 10 Pharmaceutical Manufacturers In Asia - 2024
The Asian drug market is characterized by two clusters of large, globally integrated companies and a large number of local producers that serve both local and foreign markets. Several drivers made Asia emerge as the new hub of importance in pharmaceuticals across the globe. Its manufacturing infrastructure is strong, supported well by low labor costs, advanced technology, and large-scale manufacturing capabilities, thereby making it increasingly attractive to global pharmaceutical companies.
The focus shifts to quality, safety, and compliance aspects. The strict framework for regulations and inspection has to be invested in by governments to ensure that product integrity is well maintained. The manufacturing industry is also meeting challenges, such as changes in...
Company Logo |
Company Name |
Company Management |
Company Description |
|---|---|---|---|
 |
Astellas Pharma | Kenji Yasukawa, Representative Director and Chairman of the Board | Strive to be a cutting-edge, value-driven life science innovator, working at the forefront of healthcare change to turn innovative science into the best outcomes for patients |
 |
Celltrion | Woosung Kee, Director CEO | A leading biopharmaceutical company that specializes in research, development and manufacturing of innovative therapeutics |
 |
Cipla | Dr Y K Hamied, Chairman | Investments in manufacturing capital include development of new drug delivery systems, facilitation of infrastructure supporting API and formulation developments and strengthening of platform technologies |
 |
CSPC Pharmaceutical | CAI Dongchen, Chairman | Owns two business segments of finished drugs and bulk drugs, with innovative drugs as the core development strategy |
 |
Daiichi Sankyo | Sunao Manabe, Representative Director Executive Chairperson and CEO | An innovative global healthcare company contributing to the sustainable development of society that discovers, develops, and delivers new standards of care to enrich the quality of life around the world |
 |
Eisai | Haruo Naito , Representative Corporate Officer and CEO | A company that focuses not only on developing pharmaceuticals but also the potential of corporative activities that goes beyond the provision of medicines |
 |
Otsuka Holdings | Tatsuo Higuchi, President and Representative Director & CEO | Contributes to the lives of people worldwide through innovative and creative products and services including pharmaceuticals, functional beverages and functional foods |
 |
Sino Biopharmaceutical | Tse Theresa Y Y, Executive Director and Chairwoman | Offerings include a variety of biological drugs and chemical drugs, and it occupies an advantageous position in many potential therapeutic fields such as liver disease, tumors, cardiovascular and cerebrovascular diseases, orthopedics, digestive system, immune and respiratory diseases |
 |
Sun Pharmaceutical | Dilip Shanghvi, Chairman and Managing Director | Supported by 43 manufacturing facilities, provide high-quality, affordable medicines, trusted by healthcare professionals and patients, to more than 100 countries across the globe |
 |
Takeda Pharmaceutical | Christophe Weber, President & CEO | Strive to deliver truly transformative treatments, contributing significant value to society while creating an exceptional experience for the people |
🍪 Do you like Cookies?
We use cookies to ensure you get the best experience on our website. Read more...